Stock data
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX) reported revenue of US$4.05M and net income of -US$50.22M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$4.05M | US$2.30M | -US$51.12M | -US$50.22M | — |
| 2024 | US$1.88M | US$0.74M | -US$61.04M | -US$60.66M | — |
| 2023 | US$1.50M | US$0.41M | -US$25.14M | -US$27.78M | — |
| 2022 | US$0.96M | -US$0.02M | -US$18.00M | -US$72.90M | — |
| 2021 | US$2.20M | US$1.42M | -US$53.73M | -US$64.10M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.24M | -US$11.26M | — |
| 2026-03-31 | US$0.03M | -US$4.29M | — |
| 2025-12-31 | US$1.14M | -US$22.95M | — |
| 2025-09-30 | US$0.26M | -US$10.85M | — |
| 2025-06-30 | US$0.52M | -US$9.74M | — |
| 2025-03-31 | US$2.14M | -US$6.67M | — |
| 2024-12-31 | US$1.49M | -US$33.51M | — |
| 2024-09-30 | US$0.12M | -US$13.49M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.